Related references
Note: Only part of the references are listed.Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis
Zoe Y. G. J. van Lierop et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
Antibodies against nodo-paranodal proteins are not present in genetic neuropathies
Lorena Martin-Aguilar et al.
NEUROLOGY (2020)
Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy
Carina Bunschoten et al.
LANCET NEUROLOGY (2019)
Cytokines and chemokines expression in serum of patients with neuromyelitis optica
Nanping Ai et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2019)
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins
Luis Querol et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases
Catherine Faivre-Sarrailh et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision
P. Y. K. Van den Bergh et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Share Paper
